In previous studies, we reported a marked protective role of 3-aminobenzamide (3-ABA)—a pharmacological inhibitor of PARP-1—in reducing H2O2-induced cell death in AD lymphocytes (Behrens et al., 2012; Ponce et al., 2014). This evidence concerns the gene PARP1 and Alzheimer disease.